cloricromene vs placebo | No demonstrated result | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
---|
Amputation | no data | myocardial infarction (fatal and non fatal) | 0.96 [0.02 49.14] | p=1.00 | 0 | 159 | 1 | CRAMPS, | Vascular death | 0.96 [0.02 49.14] | p=1.00 | 0 | 159 | 1 | CRAMPS, | Fatal MI | 0.96 [0.02 49.14] | p=1.00 | 0 | 159 | 1 | CRAMPS, | Non fatal MI | 0.96 [0.02 49.14] | p=1.00 | 0 | 159 | 1 | CRAMPS, | Vascular events | 0.96 [0.02 49.14] | p=1.00 | 0 | 159 | 1 | CRAMPS, | All cause death | 0.96 [0.02 49.14] | p=1.00 | 0 | 159 | 1 | CRAMPS, | Fatal stroke | 0.96 [0.02 49.14] | p=1.00 | 0 | 159 | 1 | CRAMPS, | Non fatal stroke | 0.96 [0.02 49.14] | p=1.00 | 0 | 159 | 1 | CRAMPS, | Non cerebral major bleeding | no data | Fatal bleeding | no data | TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |